Literature DB >> 1328689

Construction and characterization of a human cytomegalovirus mutant with the UL18 (class I homolog) gene deleted.

H Browne1, M Churcher, T Minson.   

Abstract

The UL18 open reading frame of human cytomegalovirus (HCMV) (which encodes a product homologous to major histocompatibility complex class I heavy chains) has been disrupted by insertion of the beta-galactosidase gene under control of the major HCMV early promoter. The recombinant virus delta UL18 showed no phenotypic differences from wild-type HCMV in terms of single-step growth curves or particle/infectivity ratios, indicating that the UL18 gene product is dispensable for the growth of HCMV in human fibroblasts in vitro. The synthesis of the mature cellular class I heterodimer is shut down in cells infected at a high multiplicity with wild-type HCMV, and a similar effect was seen in delta UL18-infected fibroblasts, suggesting that although the UL18 gene product can associate with beta 2 microglobulin, it is not directly involved in the disruption of class I assembly.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1328689      PMCID: PMC240178     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  25 in total

1.  Electron microscopic particle counts on herpes virus using the phosphotungstate negative staining technique.

Authors:  D H WATSON; W C RUSSELL; P WILDY
Journal:  Virology       Date:  1963-03       Impact factor: 3.616

2.  A cluster of dispensable genes within the human cytomegalovirus genome short component: IRS1, US1 through US5, and the US6 family.

Authors:  T R Jones; V P Muzithras
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

3.  An Fc receptor for human immunoglobulin G is located within the tegument of human cytomegalovirus.

Authors:  L M Stannard; D R Hardie
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

Review 4.  Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169.

Authors:  M S Chee; A T Bankier; S Beck; R Bohni; C M Brown; R Cerny; T Horsnell; C A Hutchison; T Kouzarides; J A Martignetti
Journal:  Curr Top Microbiol Immunol       Date:  1990       Impact factor: 4.291

5.  Characterization of a monoclonal anti-beta 2-microglobulin antibody and its use in the genetic and biochemical analysis of major histocompatibility antigens.

Authors:  F M Brodsky; W F Bodmer; P Parham
Journal:  Eur J Immunol       Date:  1979-07       Impact factor: 5.532

6.  The human cytomegalovirus receptor on fibroblasts is a 30-kilodalton membrane protein.

Authors:  H P Taylor; N R Cooper
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

7.  Expression of HLA class I heavy chains and beta 2-microglobulin does not affect human cytomegalovirus infectivity.

Authors:  M F Beersma; P M Wertheim-van Dillen; J L Geelen; T E Feltkamp
Journal:  J Gen Virol       Date:  1991-11       Impact factor: 3.891

8.  The UL16 gene of human cytomegalovirus encodes a glycoprotein that is dispensable for growth in vitro.

Authors:  J Kaye; H Browne; M Stoffel; T Minson
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

9.  Expression of a human cytomegalovirus receptor correlates with infectibility of cells.

Authors:  D M Nowlin; N R Cooper; T Compton
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

10.  Identification of a putative cell receptor for human cytomegalovirus.

Authors:  J D Adlish; R S Lahijani; S C St Jeor
Journal:  Virology       Date:  1990-06       Impact factor: 3.616

View more
  23 in total

1.  A novel bat herpesvirus encodes homologues of major histocompatibility complex classes I and II, C-type lectin, and a unique family of immune-related genes.

Authors:  Huajun Zhang; Shawn Todd; Mary Tachedjian; Jennifer A Barr; Minhua Luo; Meng Yu; Glenn A Marsh; Gary Crameri; Lin-Fa Wang
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

2.  The r144 major histocompatibility complex class I-like gene of rat cytomegalovirus is dispensable for both acute and long-term infection in the immunocompromised host.

Authors:  P S Beisser; J S Kloover; G E Grauls; M J Blok; C A Bruggeman; C Vink
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

Review 3.  Modulation of major histocompatibility complex antigen expression by viral infection.

Authors:  C R Rinaldo
Journal:  Am J Pathol       Date:  1994-04       Impact factor: 4.307

Review 4.  Investigation of CMV disease in immunocompromised patients.

Authors:  V C Emery
Journal:  J Clin Pathol       Date:  2001-02       Impact factor: 3.411

5.  Rapid degradation of the heavy chain of class I major histocompatibility complex antigens in the endoplasmic reticulum of human cytomegalovirus-infected cells.

Authors:  Y Yamashita; K Shimokata; S Saga; S Mizuno; T Tsurumi; Y Nishiyama
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

6.  Use of recombinant virus to assess human cytomegalovirus early and late promoters in the context of the viral genome.

Authors:  C P Kohler; J A Kerry; M Carter; V P Muzithras; T R Jones; R M Stenberg
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

7.  Human cytomegalovirus-infected cells have unstable assembly of major histocompatibility complex class I complexes and are resistant to lysis by cytotoxic T lymphocytes.

Authors:  A P Warren; D H Ducroq; P J Lehner; L K Borysiewicz
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

8.  The UL16 gene of human cytomegalovirus encodes a glycoprotein that is dispensable for growth in vitro.

Authors:  J Kaye; H Browne; M Stoffel; T Minson
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

9.  Restoration of cytomegalovirus antigen presentation by gamma interferon combats viral escape.

Authors:  H Hengel; P Lucin; S Jonjić; T Ruppert; U H Koszinowski
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

10.  An immortalized human fibroblast cell line is permissive for human cytomegalovirus infection.

Authors:  T Compton
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.